The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008-2013).

about

The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008-2013).

Item

http://www.wikidata.org/entity/Q48373690

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

The genotypic study of Mycobac ...... d: Galicia, Spain (2008-2013).

@en

The genotypic study of Mycobac ...... d: Galicia, Spain (2008-2013).

@nl

type

Item

label

The genotypic study of Mycobac ...... d: Galicia, Spain (2008-2013).

@en

The genotypic study of Mycobac ...... d: Galicia, Spain (2008-2013).

@nl

prefLabel

The genotypic study of Mycobac ...... d: Galicia, Spain (2008-2013).

@en

The genotypic study of Mycobac ...... d: Galicia, Spain (2008-2013).

@nl

P1476

The genotypic study of Mycobac ...... id: Galicia, Spain (2008-2013)

@en

P2093

A Fernández

http://www.w3.org/2001/XMLSchema#string

B Mejuto

http://www.w3.org/2001/XMLSchema#string

G González-Mediero

http://www.w3.org/2001/XMLSchema#string

Galician M. tuberculosis Resistance Group

http://www.w3.org/2001/XMLSchema#string

M L Pérez Del Molino

http://www.w3.org/2001/XMLSchema#string

P Alonso

http://www.w3.org/2001/XMLSchema#string

P2860

Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings

High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.

Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.

Redefining MTBDRplus test results: what do indeterminate results actually mean?

Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.

Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.

P2888

s10096-016-2730-9

P304

1795-1801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10096-016-2730-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

G Barbeito-Castiñeiras

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27586016

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis